LOS ANGELES, Dec. 05, 2016 -- M2 Compliance Incorporated, an industry-leading SEC Filing Agent and Financial Printer, is proud to announce its participation as the co-main sponsor of the 9th Annual LD Micro Main Event held at the Luxe Sunset Boulevard Hotel in Bel Air, CA on December 6th, 7th & 8th.
Following the continued success of its flagship product, M2 Compliance will be promoting its Unlimited EDGAR & XBRL Package for $4,995 per year at the 3-day event in Southern California. Based on the market cap of presenting companies at LD Micro, M2 Compliance can save each one of them a minimum of 40% versus their current vendor, which translates into several thousand dollars savings every year. An important key point is that M2 Compliance is the only SEC Filing Agent in the industry to provide the Unlimited EDGAR & XBRL Package for $4,995 per year. Other vendors have tried to imitate this offer by coming-up with their own “package deals” but none of them actually offers a truly unlimited product inclusive of all SEC filings required for public companies, certain insiders and broker-dealers, only M2 Compliance.
M2’s growth over the years hasn’t gone unnoticed, from launching a wide-range of compliance services to better assist its customers, to expanding into capital markets in Canada and the UK, the Company has proven itself over and over again as a one-stop solution for regulatory reporting requirements, guaranteeing to deliver the highest quality of service and customer support at the most cost effective rates in the industry. Public companies should take a closer look at their bill next time they file with the SEC as M2 Compliance can offer them faster turnaround times for EDGAR and XBRL combined with the highest standards of accuracy and transparency, at only a fraction of what they are currently paying.
The 9th Annual LD Micro Main Event will feature over 200 presenting companies spanning multiple industries from all over the world. As one of the largest conference venues in the microcap space, LD Micro is known for putting together a unique networking environment where attendees gather to build new relationships and source new business opportunities. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually.
About M2 Compliance
M2 Compliance™ is a full-service financial filing and printing firm and a leading partner for all your EDGAR & XBRL filing needs. With hundreds of public company clients, M2 Compliance is one of the fastest-growing regulatory compliance firms worldwide. M2 Compliance partners with its clients to provide the knowledge and service necessary to meet the SEC's ever-changing filing regulations. M2 Compliance provides high-quality, cost-effective compliance filings and production services, including EDGAR Filings, typesetting, XBRL tagging, section 16 filings, investment management services, drafting sessions, compliance hosting and more. For more information visit: www.m2compliance.com
Contact Information Rafael McGuire (310) 626-0800 [email protected]


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Italy Fines Apple €98.6 Million Over App Store Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



